Pre-diabetic
15
2
2
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.3%
2 terminated out of 15 trials
81.8%
-4.7% vs benchmark
13%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (15)
Targeted Precision Nutrition Strategy To Prevent Chronic Metabolic Diseases
The GRoceries Aimed at Increasing Nutrition Study
Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition
Evaluation of the Ottawa Model for Smoking Cessation in Diabetes Education Programs
Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons
Personalized Glucose Optimization Through Nutritional Intervention
Sleep Effectiveness and Insulin and Glucose Homeostasis
The Effect of Insoluble Yeast Beta-glucan Intake on Pre-diabetic Patients
Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk Factors
Investigation of the Ability of a Supplement to Increase Good Bacteria in the Human Intestine and Blood Sugar Levels
The Effect of Acute Lysine Administration on α-aminoadipic Acid
Effects of a Wholegrain Diet on Body Composition and Energy Balance
The Effect of Oral Carnitine Supplementation on MRS-derived Mitochondrial Function
A Mobile Based Diabetes Prevention Program
Efficacy and Safety of DLBS3233 in Prediabetic Patients